People's Pharmacy Inc. d/b/a Peoples Rx
Outcome
Austin-area pharmacy chain Peoples Rx (five retail and one compounding location) paid $200,000 civil penalty August 2023 for regulatory recordkeeping violations, improperly dispensing controlled substances to practitioners for office use, issuing prescriptions without authorization, and selling pseudoephedrine without required self-certification under the Combat Methamphetamine Epidemic Act.
Details
People's Pharmacy Inc. d/b/a Peoples Rx — DEA Civil Penalty for Multi-Violation Inspection Findings (2022–2023)
Outcome: People's Pharmacy Inc., doing business as Peoples Rx, an Austin-area pharmacy chain operating five retail pharmacies and one compounding laboratory, paid $200,000 in civil penalties in a settlement announced August 17, 2023, to resolve DEA allegations arising from a June 2022 inspection that found regulatory recordkeeping violations, improper controlled substance dispensing to practitioners for office use, prescription issuance without authorization, and sale of pseudoephedrine without required Combat Methamphetamine Epidemic Act self-certification.
Peoples Rx operated five retail pharmacy locations and one compounding laboratory in the Austin, Texas area. During a routine DEA inspection of a Peoples Rx location in June 2022, DEA Diversion Control Unit investigators from the San Antonio District Office identified multiple categories of violations.
The violations included: regulatory recordkeeping violations for controlled substances; improperly dispensing controlled substances to practitioners for office use without proper authorization — a specific regulatory category that requires practitioners to hold the appropriate DEA registration and for the dispensing to meet specific documentation requirements; issuing prescriptions without authorization; and selling pseudoephedrine products without self-certifying under the Combat Methamphetamine Epidemic Act of 2005, which requires pharmacies to submit self-certification to the DEA before selling pseudoephedrine products.
The $200,000 civil settlement was negotiated by Assistant U.S. Attorney Thomas Parnham and handled by the U.S. Attorney's Office for the Western District of Texas.
Primary Source: DEA Press Release — Austin Pharmacy to Pay $200,000 in Civil Penalties for Alleged Violations of the Controlled Substances Act (Aug. 17, 2023)
How Crucible Prevents This
Peoples Rx dispensed controlled substances to practitioners for office use without proper authorization — a specific CSA requirement that differs from standard retail dispensing. Crucible's practitioner-office-use dispensing controls, which require verified DEA registration and written authorization before any office-use controlled substance transfer, would have blocked the unauthorized transfers before they occurred.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works